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ABSTRACT
Distant metastasis is the major cause of death in colorectal cancer (CRC). Patients at high risk of developing distant metastasis
could benefit from appropriate adjuvant and follow-up treatments if stratified accurately at an early stage of the disease. Studies
have increasingly recognized the role of diverse cellular components within the tumor microenvironment in the development
and progression of CRC tumors. In this paper, we show that a new method of automated analysis of digitized images from
colorectal cancer tissue slides can provide important estimates of distant metastasis-free survival (DMFS, the time before
metastasis is first observed) on the basis of details of the microenvironment. Specifically, we determine what cell types are
found in the vicinity of other cell types, and in what numbers, rather than concentrating exclusively on the cancerous cells. We
then extract novel tissue phenotypic signatures using statistical measurements about tissue composition. Such signatures can
underpin clinical decisions about the advisability of various types of adjuvant therapy.
Introduction
Cell function and behavior cannot be fully understood without the context of their microenvironment. Communication between
cells and their surroundings allows the functional organization of cells into tissues and organs. It also plays a vital role in
maintaining tissue homeostasis by generating signals that suppress and revert malignant phenotypes1. Experiments in animal
and cell culture models have demonstrated that certain conditions of the microenvironment can cause potent cancerous cells to
revert to an almost normal phenotype2, 3. Although the normal tissue microenvironment is known to be resilient to tumorigenesis,
false signals in the microenvironment can disrupt tissue homeostasis and subsequently initiate tumors. The microenvironment
in which tumor exists is both complex and heterogeneous, inhabited by a multitude of cellular and non-cellular components
including tumor cells, extracellular matrix, tumor stroma, blood vessels, inflammatory cells, signaling molecules4–6. Studies
over the last decade have increasingly recognized the role of these different components in the development and progression of
tumors5. This paper adds to this evidence, and shows how its quantification may be automated.
Metastasis is the major cause of morbidity and death in colorectal cancer (CRC). The 5-year survival rate in CRC patients
with distant metastasis is approximately 10%, considerably smaller than 70% with regional metastasis and 90% without
metastasis7. Patients at high risk of developing distant metastasis could benefit from appropriate adjuvant and follow-up
treatments if stratified accurately. The literature reports several histopathological features carrying prognostic value for CRC
progression. Each of the features reflects competing cellular stimuli that influence tumor progression or suppression within the
microenvironment. Type, density, and relative locations of different tissue components in the tumor microenvironment are
crucial in determining progression and patient survival in CRC. For instance, the number of cytotoxic and memory T cells in
the tumor center and the invasive margin have been linked to an improved prognosis of CRC8. Similarly, numerous studies
have reported cancer-associated fibroblasts (CAFs) and desmoplasia to be important histopathological features associated with
an unfavorable prognosis for CRC and an increased mortality rate9–13. Analogous to a wound that never heals14, 15, tumors
stimulate many associated responses, wherein normal fibroblasts have been reported to acquire a cancer-associated phenotype
(5,16). Furthermore, the extent of necrosis in CRC has been reported to correlate strongly with cancer progression and patient
survival13, 16, 17. The link between necrosis and tumor progression is possibly due to the hypoxic nature of tumors, which drives
tumor infiltrating inflammatory cells, namely phagocytic macrophages and granulocytes, to secrete pro-inflammatory cytokines
which in turn promote cell proliferation4.
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In this study, we investigate the significance of tissue phenotypic and morphometric features, exploring in particular cellular
heterogeneity in tumor microenvironments, in determining metastatic potential in CRC patients diagnosed with advanced
primary tumors. Based on the AJUCC/UICC-TNM staging system18, this group of patients have a primary tumor that has
grown through the outer lining of colon wall (T3/T4), have no lymph nodes that are affected by cancer cells (N0), and may or
may not have distant metastasis at the time of diagnosis (M0/M1). Detailed quantitative analysis was performed on whole slide
images (WSIs) of CRC histology slides, stained with routine Hematoxylin & Eosin (H&E) dyes in a fully quantitative manner,
using bespoke image analysis methods to provide an objective and reproducible assessment. Quantitative analysis of various
types of cell population reveals novel tissue phenotypic features, derived from both cell-cell connection frequencies and tissue
appearance, with significant association with metastasis incidence and distant metastasis-free survival (DMFS) in the advanced
primary CRC tumors.
Results
Quantifying tissue phenotypic signatures of CRC tumors
In this study, WSIs of Hematoxylin and Eosin (H&E)-stained histological sections from 108 patients with advanced node
negative primary CRC tumors (T3/T4, N0, M0/M1) were acquired from two independent cohorts from two different institutes:
University Hospitals Coventry and Warwickshire (UHCW, 78 patients) and Hamad General Hospital (HGH, 30 patients).
Summary details of the cohorts and clinical information are given in Table 1.
CRC, like other solid tumors, is a disease of substantial heterogeneity19, 20. Different parts of the same tumor can exhibit
different features including cellular morphology, gene expression, metabolism, motility, angiogenic, proliferative, immunogenic,
and metastatic potential21. The tumor microenvironment is composed of diverse cell types; each plays a different role in
tumor development and progression — some support and promote tumor progression while others play host protective roles5.
The biological functions of cells are not only determined by their type but are also greatly influenced by their surrounding
context. It follows that tissue morphometric signatures measuring tumor heterogeneity could be computed from the analysis of
distributions and relative locations of cellular populations in the tumor microenvironment.
Here, we outline the quantification of digital tissue phenotypic signatures (see Methods for details). We divided each tumor
histology image (i.e., each WSI) into small square regions or sub-images (Fig. 1a) and analyzed the small sub-images to
obtain local characteristics that were then summarized to characterize the entire tumor section. We first applied our artificial
intelligence (AI) based algorithm22, which was recently shown to be the state-of-the-art in detecting and distinguishing between
four types of cells based on their morphology and context, to each sub-image. The four types of cells were: malignant epithelial
cells, spindle-shaped cells (normal fibroblasts, cancer-associated fibroblasts and smooth muscle cells), inflammatory cells
(eosinophils, lymphocytes and neutrophils), and necrotic debris (Fig. 1b). This allowed us to do quantification of tissue
morphological characteristics associated with tumor, based on both distributions and relative spatial locations of diverse cell
types. For each small tissue region (sub-image) in the large WSI, we then constructed a cell network (Fig. 1c). Each vertex of
the network represents a cell of a certain type, and an edge denotes a cell-cell connection between immediately neighboring
cells. Based on the distribution of cell-cell connections in the network (Fig. 1d), we then grouped the local tissue regions
into different phenotypes using an unsupervised learning approach. The six resulting connection frequency (CF) based tissue
phenotypes were visually discernible with each phenotype corresponding mainly to local areas of smooth muscle, inflammation,
tumor-stroma interface, tumor, stroma, or necrosis (Fig. 1e). Finally, we used the ratio of the area of each CF tissue phenotype
to the total tissue area to give digital tissue phenotypic signature of each tumor sample (Methods).
To further examine the extent to which the aforementioned automatically derived cell-cell CF tissue phenotypes correlate
with known tissue types, we also quantified the tissue types by means of appearance based (AP) tissue segmentation. The
tissue content of each WSI was automatically segmented into the following eight categories: tumor, stroma, loose connective
tissue, normal/hyperplastic mucosa, smooth muscle, necrosis, fat, and inflammation (Fig. S1). We then investigated correlation
between the CF and AP based tissue phenotypes. These are smooth muscle, inflammation, tumor, stroma, and necrosis. The
Spearman correlation coefficients for individual pairs of CF and AP features range from 0.427 to 0.698 (Fig. S2), indicating
moderate correspondence between the automatically-derived phenotypes and the underlying tissue types.
In addition to the phenotypic and standard clinical features, we considered the following automatically-derived features:
Morisita index23, stroma-tumor ratio9, 11, 12, and necrosis-tumor ratio13, 16, 17. These features have previously been identified as
having prognostic significance for CRC or other malignancies. Morisita index measures the spatial coexistence of inflammatory
cell and malignant epithelial cells23. Stroma-tumor ratio is defined as the proportion of the total area of stroma to the total area
of combined stroma and tumor in the tissue. Necrosis-tumor ratio is defined in the similar manner as that of stroma-tumor ratio
(Methods). It is worth noting that in the above studies, the stroma-tumor ratio and necrosis-tumor ratio were semi-quantitatively
assessed on manually selected small regions of histological slides. In contrast, we measured these quantities with greater
precision and using all regions of our WSIs, thus avoiding subjective bias.
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Association between phenotypic and clinical features
Here, we determined the strength of association between the CF tissue phenotypic features and standard clinical features
normally used in routine prognostication of colon cancer (Table 2). The clinical features included tumor differentiation, tumor
histological type, and primary tumor (T) stage. For example, to check whether there is association between the CF inflamation
ratio and the T stage, we test if the distribution of CF inflammation ratio of the group of samples that are annotated as pT3 stage
is significantly different from the distribution of samples that are annotated as pT4 stage using Mann-Whitney U test (also
known as Wilcoxon rank-sum test).
We found statistically significant association between CF inflammation ratio and T stage (p-value = 0.002) and between
CF tumor ratio and tumor differentiation (p-value = 0.033). Nonetheless, the relatively small values of the coefficients of
determination (CF inflammation ratio vs. T stage: r2 = 0.092; CF tumor ratio vs. differentiation: r2 = 0.042) indicate that
CF inflammation ratio and CF tumor ratio are only weakly associated with T stage and tumor differentiation, respectively.
There is no statistically significant association between other pairs of the CF phenotypic features and the standard clinical
features. Altogether, these results suggest that the CF tissue phenotypic features are not strongly associated with standard
clinical features and, therefore, are potentially new features whose prognostic significance is worth further investigation.
Logistic regression analysis
To assess the significance of each phenotypic feature in identifying a patient’s risk of having distant metastasis at the time of
diagnosis or future progression, we carried out logistic regression analysis. Odds ratio factor and 95% confidence interval (CI)
estimates were obtained for each feature to quantify the risk of distant metastasis incidence associated with the phenotypic
features (Methods).
The results show that CF smooth muscle and inflammation ratios are statistically significant (p-value < 0.05) in univariate
analysis (Table 3). Moreover, when adjusted for the effects of the standard clinical parameters in multivariate analysis, CF
smooth muscle and inflammation ratios are statistically significant features (p-value < 0.05), independent of other standard
clinical features (Table 3 and Table S1). The interquartile change in CF smooth muscle ratio increases the odds of distant
metastasis by a factor of 2.258 (95% CI: 1.117 - 4.565) in univariate analysis and by 2.350 (95%CI: 1.132 - 4.876) in multivariate
analysis. The interquartile change in CF inflammation ratio, on the other hand, decreases the odds by a factor of 0.279 (95%
CI: 0.119 - 0.656) in the univariate analysis and 0.307 (95%CI: 0.126 - 0.749). Despite the fact that CF smooth muscle
and inflammation ratios are separately shown to be statistically significant in both the univariate and multivariate analyses,
when considered together in the multivariate model (Table S1), their joint contribution towards the prediction of metastasis
development becomes less clear. This is likely due to a moderate degree of correlation (ρ=-0.652) between the features. Thus,
when one is used, the other should probably be disregarded.
Next, we investigated if the above statistical results could be achieved by means of the AP smooth muscle ratio and AP
inflammation ratio features. Only the AP inflammation ratio is shown to be statistically significant in the univariate analysis
(p-value = 0.027, Table 3) and marginally significant in the multivariate analysis (p-value = 0.056, Table 3).
Distant metastasis-free survival analysis
Next, we investigated the prognostic significance of various features, using DMFS as a criterion. The analysis was carried out
on all cases from the UHCW cohort (78 cases), for which survival data were available. In our multivariate analysis, the effect of
individual features was adjusted for the effect of standard clinical features.
The tissue CF phenotypic features (smooth muscle, inflammation, and stroma ratios) and the AP phenotypic feature
(inflammation ratio) were shown to be influencing features in determining the DMFS probability of the patients under Cox
proportional hazards models (p < 0.05, Table 4, and Table S2). In particular, the effect of the interquartile change in CF smooth
muscle ratio is to increase the hazard by 2.138 times (95% CI: 0.188 – 0.388) in the univariate analysis and by 2.467 times (95%
CI: 1.062 – 5.73) in the multivariate analysis. The interquartile change in AP inflammation ratio affects the DMFS probability
by reducing the hazard by a factor of 0.401 (95% CI: 0.026 - 0.075) in the univariate analysis and by a factor of 0.431 (95% CI:
0.224 - 0.832) in the multivariate analysis. In addition, when CF smooth muscle and AP inflammation are compared together in
the same multivariate model, the effects of AP inflammation ratios on the DMFS probability vanishes (Table S2). This is likely
due to the correlation between these features (ρ = -0.252).
The interquartile change in CF inflammation ratio influences the survival probability by decreasing the hazard by a factor of
0.412 (95% CI: 0.204 - 0.934) in the univariate analysis and by a factor of 0.413 (95% CI: 0.201 – 0.849) in the multivariate
analysis. However, the effect of CF inflammation ratio is only marginally significant (p-value = 0.051) when adjusted by the
standard clinical parameters in the multivariate analysis. Interestingly, CF stroma ratio also shows up as statistically significant
in the univariate analysis (p-value = 0.032, hazard ratio factor = 0.475, 95% CI: 0.252 - 0.896).
We found that lower values of CF smooth muscle ratio and higher values of CF inflammation, CF stroma, and AP
inflammation ratios were associated with low 5-year survival probabilities (Fig. 2 left and Fig. S3d left). Furthermore, there are
statistically significant differences between the survival distributions of cases when stratified by CF smooth muscle, CF stroma,
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and AP inflammation ratios (p-value < 0.05, Table 4, Fig. 2 right). Stratification by other features does not yield statistically
significant results (Fig. S3).
In summary, CF smooth muscle and AP inflammation ratios are consistently shown to be important prognostic factors for
DMFS across three different types of survival analyses, including univariate Cox regression analysis, multivariate Cox analysis,
and log-rank test. Nonetheless, they are not shown to be independent of each other and therefore when one is used, the other
should probably be disregarded.
Discussion
The goal of this study was to investigate the prognostic significance of novel image-based quantitative morphometric features
derived from diverse cellular populations that constitute the tumor microenvironment of CRC with advanced primary tumors
(T3/T4, N0, M0/M1).
Digital Phenotypic Features vs Histological Features. To fully explore the rich microscopic level information available in
a tissue section, we have developed an automated system to provide quantitative measurements and avoid bias due to observer
variability. The analysis was conducted on WSIs of H&E-stained formalin-fixed paraffin-embedded (FFPE) histological
sections. Unlike previous works that identify diverse cellular components in a tumor section24, 25, our morphometric features
are not limited to tumor cells, lymphocytes, and stromal cells, but also include other types of inflammatory cells, spindle-shaped
cells, and necrotic debris. In addition, we explored the relationship between these cellular components through a cell-cell
network in order to characterize the morphological and tissue phenotypic heterogeneity of tumor. Our system did not adopt
a commonly used approach26, 27 that calculates a large number of features followed by feature selection methods to select a
handful of features suitable for the objectives of the analysis. Although such an exploratory approach has proved successful
in some applications26, 27, the resulting features may not be easily interpretable in clinical terms. Moreover, if sufficiently
many features are tried, it is likely that one of them will turn out to be “statistically significant” and so this approach requires
follow-up tests of reproducibility. Instead, we investigated a small set of meaningful quantitative features, automatically found
through unsupervised phenotyping and segmentation.
Our systematic analysis shows that (a) the CF smooth muscle and CF inflammation ratios are potentially independent
markers predicting the occurrence of distance metastasis (binary logistic regression analysis) and (b) the CF smooth muscle and
AP inflammation ratios are potential prognostic markers affecting 5-year DMFS for CRC patients diagnosed with advanced
primary tumor (Cox proportional hazards regression analysis). CF smooth muscle ratio essentially measures the amount of
the smooth muscle that is part of the colon wall. It quantifies the extent of spread and potential advancement of the tumors
— the concept is related (but not similar) to other measures such as T stage, tumor-stroma ratio9, 11, 12, and tumor border
configuration28, 29. Low CF smooth muscle ratio is strongly associated with favorable prognosis. CF inflammation and AP
inflammation ratios largely measure the amount of inflammation within the tumor tissue. High inflammation ratio is strongly
associated with favorable prognosis, which supports the host-protective role of inflammatory cells in CRC that has been
described by several studies8, 30, 31. From this observation, one may hypothesize about the biological relevance of each of our
automatically derived tissue phenotypes for tumor development and progression.
The prognostic value of stroma-tumor ratio9, 11, 12 and necrosis-tumor ratio13, 16, 17 could not be confirmed in this study. It
should be emphasized that, in those studies, both the ratios were semi-quantitatively measured in manually selected tumor-rich
areas and were inevitably prone to observer bias. By contrast, our study measured these quantities in a fully automated and
quantitative manner from all regions of the tumor section and therefore can be considered to be more objective and reproducible.
Uncertainty found in our analysis pertaining to the prognostic impact of standard clinical factors has also been confirmed
in existing literature32–37. Despite the fact that tumor differentiation has been consistently shown to be a prognostic feature
independent of stage38–42, the conventional grading process is subjective by its very nature and can exhibit a substantial degree
of observer variability32, 33. Inconsistency in grading is likely to occur in this study since samples from different cohorts
were graded by different pathologists (UHCW: DS, HGH: IM). It is also worth noting that according to the revised WHO
criteria43, only poorly differentiated tumor histology without mismatch repair protein deficiency is considered a high-risk
factor. Presence of the mucinous histologic type in general is not an independent prognostic factor, given that available results
are contradictory34, 35. Recent data have demonstrated the primary tumor extent (T4 stage) to be a likely prognostic factor
for recurrence/metastasis44–46. Nevertheless, like other semi-quantitative features, there have been reports of variability in
assessment of the degree of tumor extent36, 37. Results from our analysis also indicate that T4 tumors have adverse DMFS
outcome compared to T3 tumors, though the difference is not statistically significant (p-value = 0.156).
The majority of samples in this study come from patients diagnosed with stage II (Dukes stage B) CRC. This is characterized
by advanced primary tumor with neither lymph node nor distant metastasis involvement (T3/T4, N0, M0). Stage II CRC consists
of a heterogeneous population; some subgroups appear more likely to develop distant metastasis than others. Although adjuvant
chemotherapy treatment is effective in other stages of the disease, there is a limited incremental benefit that stage II CRC
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patients could derive from this type of treatment in general47–49. Due to the high financial cost and morbidity of the treatment
coupled with uncertainty over which patients will relapse, there has long been a debate as to whether adjuvant chemotherapy
treatment should be given to the patients, since a majority of the patients will already have been cured by surgical resection
alone. In the absence of molecular or genetic predictive markers for chemotherapy response44, 50, 51, improved prognostication
accuracy seems to be the only key to better identify candidates who could potentially benefit the most from systemic therapies
and thereby avoid unnecessary overtreatment as well as provide more efficient use of healthcare resources.
Even though several histological features have been demonstrated to be potential prognostic markers for recurrence or
distant metastasis in stage II CRC, their prognostic significance is less clear and needs further validation. Primary tumor (T)
stage and the number of lymph nodes examined have been recommended as risk factors by the National Comprehensive Cancer
Network52. However, the results from our analysis do not support the T stage as a risk factor. Moreover, there is a controversy
as to whether examining more lymph nodes can, in fact, reduce tumor staging error and in turn result in improved stage II
patient survival53, 54. High-frequency microsatellite instability has been associated with improved disease-free survival in one
study51 while in another study the effect was the opposite50. Gene expression profile is another factor that has shown promise
for prediction of recurrence44, 45.
Study Limitations. Based on the makeup of our dataset and the results from our analysis, we hypothesize that high CF
smooth muscle ratio and low CF or AP inflammation ratios are potential risk factors for distant metastasis in stage II CRC.
There are nevertheless some limitations of this study as described below.
Firstly, although our cell detection and classification approach22 was developed to be robust to a certain degree of variation
of images arising from factors such as stain inconstancy, batch effects, failed autofocus, and artefacts in the tissue preparation
process, it remains to be tested if the degree of variation is excessive. Good image quality is therefore critical if the system is to
produce accurate results. This issue can be addressed by careful tissue preparation and slide scanning.
Secondly, due to the nature of the H&E stain and cellular morphology, our system is capable of identifying only a limited
number of cell categories that are somewhat coarse. IHC stains could provide an effective means of identifying more specific
cell types, such as different types of immune cells and fibroblasts (normal fibroblasts or CAFs), at the additional costs of IHC
slide preparation and associated antibodies.
Thirdly, the phenotyping proposed in this work was done on the basis of local cell-cell connection frequencies and also on
the basis of appearance and other important contextual information such as tissue textures. This, on the one hand, can be seen
as a limitation of the proposed quantitative tissue phenotyping approach, as it relies on local cell populations to generate global
statistics. On the other hand, a number of studies have reported that normal cells of various types undergo transformation
when coming into contact with tumor cells, thus resulting in some of the previously normal cells exhibiting new biological
functions different from the original ones. The proposed approach focuses on cellular morphology and cellular context and
avoids influences from other possibly misleading contextual information.
Finally, our analysis was based on a single dataset consisting of two independent cohorts from different institutes. To further
confirm the reproducibility of the results and generalizability of our automated histologic quantification system, large-scale
validation using independent cohorts from multiple institutes is required. To be translated into clinical practice, these limitations
will need to be carefully addressed.
The Outlook. With the increasing uptake of digital slide scanning technology in histopathology laboratories, digitized WSIs
will gradually replace glass slides in routine pathology workflow55. This presents an opportunity to advance image analytical
techniques and computational algorithms for quantitative analysis of tissue morphology and consequently to provide an accurate
and reproducible means for the diagnosis and prognostication of cancers. This is the first step towards effective treatment,
decision-making, and personalized medicine with computational support. In this work, we have demonstrated the usefulness
of such morphometric tools to reveal prognostic features in CRC. Our morphometric analysis is not restricted to images of
FFPE CRC tissues but is also applicable to frozen tissue images as well as to images from different types of cancers. This
morphometric approach was not designed to replace pathologists, but rather to provide additional information to assist in their
diagnostic decision-making and risk stratification. Another potentially important direction would be to investigate potential
associations between genomic alterations and digital tissue phenotypic signatures reflecting measurable aspects of in the tumor
microenvironment.
Methods
Experimental Design
The main objective of this study was to assess the significance of tissue phenotypic features for determining distant metastasis
in advanced primary CRC. Specifically, we asked what quantitative tissue phenotypic features are biologically meaningful
and important in predicting the concurrence at the time of diagnosis or subsequent development of distant metastasis and the
5/16
distant-metastasis-free survival. Based on results from our statistical analyses, we have shown that digital tissue phenotypic
features are independent prognostic factors for distant metastatic potential in CRC patients with advanced primary tumors
(T3/T4, N0, M0/M1). The sample size for logistic and Cox proportional hazards regression analyses was calculated based
on the concept of events per variable56–58 which indicates that a minimum of 30 metastatic subjects would be sufficient to
control for a type I error rate at 7%, 95% CI coverage of 93% , and a relative bias of 7% of the estimate in the Wald test. We
retrospectively recruited CRC subjects with advanced primary tumors. Cases without a 5-year distant metastasis status were
excluded and the enrollment was stopped when the calculated sample size was reached. Our analyses were conducted on
H&E-stained WSIs of tumor sections. After reviewing the WSIs, we further excluded outlier cases whose tissue section had no
tumor. In view of the limited number of cases, randomization was not used in any experiments.
Patient and clinical information
This study involved two independent cohorts of CRC patients from two institutes. The first cohort consisted of 78 patients
initially admitted for CRC treatment during the years 2006 to 2010 at University Hospitals Coventry and Warwickshire
(UHCW), Coventry, UK. The second cohort comprised 30 patients admitted during the years 2007 to 2012 at Hamad General
Hospital (HGH), Doha, Qatar. For each case, clinical data included tumor histological type, differentiation, stage of the primary
tumor (T), lymph node metastasis (N), and distant metastasis (M). The 5-year DMFS data were available only for UHCW cases.
All CRC patients were diagnosed with locally advanced tumors (T3/T4) and negative lymph node (N0). Some patients appeared
to have distant metastatic tumors at the time of diagnosis (M1), but the majority did not (M0). The TNM classification was
reviewed and conducted according to the AJUCC/UICC-TNM staging system18. Summary details of the clinical information
are given in Table 1.
The data used for this study including the WSIs and clinical information was provided after de-identification and informed
patient consent was obtained from all subjects. Ethics approval for this study was obtained from the National Research Ethics
Service North West (REC reference 15/NW/0843). All the experiments were carried out in accordance with approved guidelines
and regulations.
Histological samples and Imaging
For each case, tissue sections were prepared from an FFPE tumor tissue block and were then stained with H&E. Each tissue
section was prepared in the pathology laboratory of the UHCW hospital. Histological slides were digitally scanned using the
Omnyx VL120 Scanner (GE Omnyx, LLC) with an ×40 setting (equivalent to 0.275 µm/pixel). The scanned images were
manually reviewed to control for failed autofocus. The tumor slides of all the cases were reviewed by the pathologists (DS, YT,
and IM) and the slides showing the deepest invasion into the bowel wall and/or the worst differentiated parts of the tumor, were
selected for analysis.
Detection and classification of cells based on nuclear appearance
Two separate convolutional neural networks (CNNs) were trained, one for detection and another for classification of cells22. A
spatially-constrained CNN produced a probability map assigning to each pixel the probability of being the center of a cell.
Subsequently, the locations of cells were estimated by the local maxima of the probability map. To classify a detected cell,
multiple small sub-images in the neighborhood of the detected cell were extracted and then fed to the neighboring ensemble
predictor (NEP). The NEP was trained to classify 4 cell types: malignant epithelial cells, inflammatory cells (including
eosinophils, lymphocytes, and neutrophils), spindle-shaped cells (including normal fibroblasts, CAFs, and smooth muscle
cells), and necrotic debris.
The training and validation of the two algorithms were carried out on a dataset consisting of more than 20,000 cells,
annotated by an experienced pathologist and a trained observer. The pixel resolution of images in the dataset was reduced to
0.55 µm (equivalent to using a ×20 microscope objective). This dataset consisted of certain H&E-stained WSIs from cases that
were initially excluded from the study. Based on a 2-fold cross-validation, the cell detection algorithm achieved an F1-score
of 0.802 and the cell classification algorithm a multiclass AUC score59 of 0.917. For more details of the cell detection and
classification method, see Sirinukunwattana et al.22.
Quantifying local tissue characteristic
We first split a WSI into small non-overlapping image tiles of size 200×200 µm2 (Fig. 1a), which was within the limit of
effective intercellular communication distance60. For each image tile, a cell network (in computational terms, a graph) was
constructed based on cell detection and classification results (Fig. 1b). The vertices of the network represent cells of different
types. The network itself is the associated Delaunay triangulation (Fig. 1c), so that an edge represents a connection between a
pair of neighboring cells. The edges connecting cells in one tile with cells in an adjacent tile were not considered. Since there
are 4 cell classes, there are 10 possible pairs of cell-cell connections in the network. We then used the distribution of different
cell-cell connection types (Fig. 1d) to characterize a given image tile.
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Tissue phenotyping using cell-cell connection frequencies
In order to group image tiles into different phenotypes, we first calculate a feature vector based on cell-cell connection
frequencies. We consider the 4-element set A= {M, I,S,N}, where M denotes the malignant epithelial type, I the inflammatory
type, S the spindle-shaped type, and N the necrotic debris type. We also identify A with 1,2,3,4 and define an indexing set
Q= {(i, j)|i≥ j}. Let h= [h(i, j)|(i, j) ∈ Q] ∈ R10 be the ten-dimensional cell-cell connection frequency vector representing
the frequencies of all cell-cell connections, where h(i, j) ∈ [0,1] denotes the proportion of connection frequencies between cells
of types i and j. We calculated this vector for every image tile extracted from every WSI in the dataset.
Next, we performed k-medoid clustering on all frequency vectors, calculated as above, for all tiles in all WSIs in the
dataset in order to group image tiles into different phenotypes. This unsupervised algorithm (we used the k-medoid algorithm
implemented in Matlab 2016b) automatically finds a set of medoids — representative frequency vectors for tile phenotypes
within the data — and assigns a phenotype label to each tile according to its nearest medoid. We employed the Chi-squared
distance between a frequency vector h and a medoid m given by:
d(h,m) = ∑
k∈Q
(hk−mk)2
hk+mk
We initialized the medoids randomly and ran the clustering algorithm 100 times for each trial. We then used the results from the
replicate that yielded the smallest total sum of distances between the frequency vectors and their corresponding medoids. The
criteria used to determine the number of phenotypes k were the similarity between the phenotypes and the correlation between
tissue morphometric features derived from the phenotypes (described below). The similarity between a pair of phenotypes was
measured in terms of the Chi-squared distance between the pair of medoids representing the phenotypes. Correlation between a
pair of features was measured by the Spearman correlation coefficient. In order to find a suitable number of distinct phenotypes
k, we chose the maximum number of phenotypes that produced relatively high values of Chi-squared distance and relatively low
values of correlation between distinct features. A distance value less than 0.2 and a correlation coefficient value greater than 0.8
were considered undesirable. We found that k=6 is the maximum number of phenotypes that satisfies both criteria (Fig S4).
Examples of image tiles from different tissue phenotypes discovered using cell-cell connection frequencies are shown in
Fig. 1e. As can be observed in Fig. 1e, the six connection frequency (CF) based phenotypes found automatically corresponded
well with the following distinct tissue phenotypes: smooth muscle, inflammation, tumor-stroma interface, tumor, stroma, and
necrosis.
Tissue phenotyping based on appearance
We also trained a deep learning based CNN for patch-based tissue phenotyping, in which the following 9 categories of image
patches were explicitly considered: normal, non-tissue background, loose connective tissue (submucosa), fat (adipose), stroma
(desmoplasia), inflammation, necrosis, smooth muscle, and tumor. Each image patch was of size 32×32 pixels with a pixel
resolution of 2.2 µm/pixels ( 5× objective). The architecture of the CNN was a simplified version of that proposed by Simonyan
et al.61.
In developing this appearance (AP) based approach to tissue phenotyping, we used a dataset consisting of 193 sub-images,
each of size 1,346×982 pixels. These images were extracted from WSIs of cases that were initially excluded from the study.
A trained observer (KS) annotated all images. We randomly split the images into three parts with 52.5% for training, 17.5%
for validation, and 30% for testing. Each WSI contributed images to only one part of the split. For training and validation,
we extracted multiple patches of size 32×32 pixels from the training and validation images. We selected the version of the
algorithm that yielded the best performance on the validation part. In testing, for each test image, we extracted patches in a
sliding-window fashion and classified each of them separately before merging the results together to obtain a segmentation
result for the whole image. The correct classification accuracies for the 9 tissue phenotypes were as follows: normal 98.9%,
non-tissue background 99.9%, loose connective tissue (submucosa) 98.4%, fat (adipose) 97.9%, stroma (desmoplasia) 90.4%,
inflammation 99.3%, necrosis 98.2%, smooth muscle 97.5%, and tumor 96.0%.
We ran the trained segmentation algorithm on the 108 H&E-stained WSI images, used in the analyses. Examples of the
segmentation results can be seen in Fig. S1. Furthermore, as a quality control, segmentation results of 10 images (out of 108
images) were randomly selected and then reviewed by expert pathologists (DS, IC).
Automatically-derived tissue phenotypic features
The CF and AP based tissue phenotypic features were calculated as follows:
phenotype ratio =
area of the tissue phenotype
total tissue area
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Here, the tissue area was computed from all tissue types excluding the normal and fat regions. The other tissue phenotypic
features were quantified as follows:
stroma-tumor ratio =
stroma area
stroma area+ tumor area
necrosis-tumor ratio =
necrosis area
necrosis area+ tumor area
where stroma, tumor, and necrosis areas were obtained from the AP based phenotyping results.
Statistical analyses
Our analysis did not distinguish well differentiated from moderately differentiated tumors—as recommended by Compton et
al.62, 63, this helps to avoid contradictory labelling by two different observers, or even by a single observer, looking at the same
sample on two different occasions. Missing data were filled in with 100 imputed values using the multiple imputation method
implemented in the R ‘mice’ library64. Analyses were performed on every imputed dataset and the results were combined to
yield an overall estimate65. The significance level was set to 0.05 for all the tests described below.
Association between the tissue phenotypic and standard clinical features was tested by the Mann-Whitney test and the
strength of association was determined through coefficients of determination (r2) of the test66, 67. The median p-value and r2
were reported for a variable with multiple imputed values. We used the ‘rms’ library in R68 to fit logistic regression models, to
calculate the area under the receiver operating characteristic curve (AUC), and to perform survival and bootstrap analyses.
Logistic regression analysis was performed to assess the predictive power of each phenotypic feature in identifying patients
with concurrent distant metastasis at the time of diagnosis or a propensity for distant metastasis development. Effects of the
automatically-derived features were gauged after adjusting for the standard clinical variables in multivariate logistic regression
models. A total of 108 cases (78 UHCW and 30 HGH) were used in the analysis. The 5-year metastasis status was treated
as a binary outcome and features were treated as predictors in regression models. Estimated odds ratio and its 95% CI were
obtained for each feature to quantify the risk of distant metastasis development associated with the feature. We reported the
factor of change in odds ratio when the value of a feature changes from the baseline value to the new value. For a continuous
feature, the baseline and the changed values were set to the 1st and 3rd quartiles of the feature. Furthermore, likelihood ratio
p-values were computed to assess goodness of fit of predictive models contributed by various features.
Survival analysis was performed to determine the prognostic value for DMFS associated with each feature. Univariate
and multivariate Cox proportional hazards regression analyses were conducted on 78 cases from the UHCW cohort for which
DMFS data were available. The former was used to evaluate the prognostic impact of each feature separately while the latter
was used to assess the prognostic value of image-based tissue phenotypic features while adjusting for the effects of the clinical
features. Rao’s score test and Wald test were employed in the univariate and multivariate analyses, respectively, to test whether
the regression coefficient corresponding to a particular feature in the Cox proportional hazards model was nonzero. Note that
the score test is equivalent to the log-rank test when only a single categorical feature is considered in the model69. Hazard ratio
and 95% CI estimates were obtained for each feature. To internally validate the performance of each fitted Cox proportional
hazards model in predicting the survival probability, a bootstrap routine70 with 100 resampling replicates was employed to
estimate the AUC. The statistical significance difference between survival stratifications was determined through the log-rank
test using the R ‘survival’ library71. The cutoff with minimum p-value was used for stratification, and the p-value was adjusted
according to Altman’s correction72 in case of a continuous feature.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on
reasonable request. Extracted image features and codes to perform statistical analyses will be included in the Supplementary
Information files once the manuscript has been accepted for publication.
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Clinical feature UHCW cohort HGH cohort Total
Number of cases 78 30 108
Tumor histological type
Adenocarcinoma 69 26 95
Mucinous 9 3 12
Not available 0 1 1
Tumor differentiation
Well differentiated 6 6 12
Moderately differentiated 39 20 59
Poorly differentiated 17 4 21
Not available 16 0 16
T stage
pT3 60 26 86
pT4 18 4 22
5-year metastasis
No 52 23 75
Yes 26 7 33
Median metastasis-free
survival (year)
With distant metastasis 1.0410 Not available 1.0410
Without distant metastasis >5 Not available >5
Table 1. A summary of clinical data.
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Feature Differentiation Histological type T stage
p-value r2 p-value r2 p-value r2
CF smooth muscle ratio 0.711 0.001 0.567 0.003 0.834 0
CF inflammation ratio 0.168 0.018 0.957 0 0.108 0.024
CF tumor-stroma
interface ratio
0.339 0.008 0.608 0.002 0.002 0.092
CF tumor ratio 0.033 0.042 0.587 0.003 0.466 0.005
CF stroma ratio 0.655 0.002 0.949 0 0.362 0.008
CF necrosis ratio 0.321 0.009 0.267 0.011 0.973 0
Table 2. Association between the CF tissue phenotypic features and standard clinical features. Mann-Whitney test’s p-value
and coefficient of determination (r2) are used to assess the association between features. The results with p-value less than 0.05
is considered statistically significant (bold).
Feature Univariate MultivariateOdds ratio factor p-value AUC Odds ratio factor p-value AUC
Standard histological features
Differentiation (MD→ PD) 1.729 (0.622,4.807) 0.298 0.525
Histological type (Adenocarcinoma→Mucinous) 0.752 (0.190,2.984) 0.679 0.491
T stage (pT3→ pT4) 2.283 (0.869,5.995) 0.097 0.559
Connection frequency (CF) based tissue phenotypic features
CF smooth muscle ratio (0.167→ 0.372) 2.258 (1.117,4.565) 0.010 0.641 2.350 (1.132,4.876) 0.008 0.638
CF inflammation ratio (0.042→ 0.138) 0.279 (0.119,0.656) 0.009 0.661 0.307 (0.126,0.749) 0.022 0.623
CF tumor-stroma interface ratio (0.122→ 0.229) 1.326 (0.722,2.435) 0.644 0.503 1.177 (0.623,2.224) 0.800 0.556
CF tumor ratio (0.079→ 0.229) 0.488 (0.244,0.976) 0.111 0.623 0.520 (0.252,1.070) 0.187 0.607
CF stroma ratio (0.174→ 0.275) 0.567 (0.334,0.962) 0.094 0.595 0.585 (0.340,1.007) 0.139 0.580
CF necrosis ratio (0.022→ 0.053) 0.713 (0.366,1.386) 0.284 0.539 0.738 (0.371,1.469) 0.254 0.539
Appearance (AP) based tissue phenotypic features
AP smooth muscle ratio (0.136→ 0.330) 1.449 (0.755,2.779) 0.513 0.511 2.075 (0.970,4.437) 0.125 0.562
AP inflammation ratio (0.025→ 0.070) 0.422 (0.206,0.865) 0.027 0.618 0.472 (0.225,0.987) 0.056 0.585
Other features
Morisita index23 (0.344→ 0.529) 0.973 (0.533,1.775) 0.916 0.494 0.868 (0.461,1.632) 0.866 0.541
Stroma-tumor ratio9, 11, 12 (0.400→ 0.613) 0.898 (0.515,1.567) 0.284 0.571 0.852 (0.481,1.509) 0.329 0.569
Necrosis-tumor ratio13, 16, 17 (0.077→ 0.224) 0.556 (0.274,1.129) 0.247 0.551 0.577 (0.278,1.197) 0.272 0.578
Table 3. Prognostic values of different features according to the logistic regression analysis. Each morphological feature is
adjusted by the standard histological features in the multivariate analysis. The statistical significance of each feature is assessed
by the likelihood ratio test’s p-value. An interquartile change for a continuous variable or categorical change for a categorical
variable is noted by (x→ y). A 95% confidence interval of the estimate of odds ratio factor is noted by (x,y). A statistically
significant result at the 0.05 is highlighted in bold. AUC in the multivariate analysis refers to the AUC of the multivariate model
rather than an individual feature.
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Feature Univariate MultivariateHazard ratio
factor
Score test
p-value
Log-rank test
p-value AUC
Hazard ratio
factor
Wald test
p-value AUC
Standard histological features
Differentiation (MD→ PD) 1.275 (0.496,3.281) 0.539 0.539 0.496
Histological type (Adenocarcinoma→Mucinous) 0.580 (0.137,2.449) 0.450 0.450 0.512
T stage (pT3→ pT4) 1.814 (0.787,4.181) 0.156 0.156 0.542
Connection frequency (CF) based tissue phenotypic features
CF smooth muscle ratio (0.167→ 0.372) 2.138 (0.922,4.955) 0.016 0.036 0.633 2.467 (1.062,5.730) 0.008 0.623
CF inflammation ratio (0.042→ 0.138) 0.412 (0.204,0.834) 0.039 0.258 0.608 0.413 (0.201,0.849) 0.051 0.582
CF tumor-stroma interface ratio (0.122→ 0.229) 1.120 (0.619,2.029) 0.931 0.445 0.462 1.054 (0.575,1.934) 0.968 0.530
CF tumor ratio (0.079→ 0.229) 0.584 (0.303,1.125) 0.174 0.399 0.584 0.520 (0.304,1.184) 0.276 0.566
CF stroma ratio (0.174→ 0.275) 0.475 (0.252,0.896) 0.032 0.047 0.627 0.469 (0.245,0.895) 0.062 0.616
CF necrosis ratio (0.022→ 0.053) 0.689 (0.343,1.386) 0.233 0.595 0.535 0.619 (0.302,1.267) 0.202 0.552
Appearance (AP) based tissue phenotypic features
AP smooth muscle ratio (0.136→ 0.330) 1.515 (0.762,3.010) 0.467 0.759 0.514 2.086 (1.025,4.247) 0.127 0.563
AP inflammation ratio (0.025→ 0.070) 0.401 (0.216,0.742) 0.001 0.003 0.654 0.431 (0.224,0.832) 0.009 0.625
Other features
Morisita index23 (0.344→ 0.529) 0.844 (0.458,1.556) 0.861 0.795 0.507 0.742 (0.397,1.387) 0.646 0.502
Stroma-tumor ratio9, 11, 12 (0.400→ 0.613) 0.880 (0.517,1.498) 0.607 0.529 0.519 0.813 (0.464,1.424) 0.583 0.515
Necrosis-tumor ratio13, 16, 17 (0.077→ 0.224) 0.647 (0.328,1.275) 0.281 0.370 0.554 0.652 (0.331,1.286) 0.216 0.575
Table 4. Prognostic values of different features according to the Cox proportional hazards regression analysis on the UHCW
cohort. Each morphological feature is adjusted by the standard histological features in the multivariate analysis. An
interquartile change for a continuous variable or categorical change for a categorical variable is noted by (x→ y). A 95%
confidence interval of the estimate of hazard ratio factor is noted by (x,y). A statistically significant result at the 0.05
significance level is highlighted in bold. AUC in the multivariate analysis refers to the AUC of the multivariate model rather
than an individual feature.
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Figure 1. Profiling tissue morphometric phenotypes. A WSI was divided into small regions of size 200×200 µm2 (a).
Cellular components in the image were localized and classified into 4 different cell types, including malignant epithelial cell,
inflammatory cell, spindle-shaped cell, and necrotic debris, based on their nuclear morphology and surrounding tissue context
(b). A cell network was subsequently constructed from the cell detection and classification results, in which nodes in the
network represent cells and edges conceptualize relationships among them (c). A distribution of cell-cell connections was
calculated for each small region (d). According to their distributions of cell-cell connections, tissue regions were profiled into 6
different phenotypes (e).
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Figure 2. Prognostic values of tissue phenotypes in the univariate survival analysis. (Left) A 5-year DMFS estimate with
respect to the CF smooth muscle ratio (a), CF stroma ratio (b), and AP inflammation ratio (c). The gray shaded regions indicate
the 95% confidence intervals of the estimates. (Right) Kaplan-Meier curves stratified by the CF smooth ratio (a), CF stroma
ratio (b), and AP inflammation ratio (c). A log-rank p-value was computed for each pair of Kaplan-Meier estimates.
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